Raghuvir Synthetics Limited (BOM:514316)
India · Delayed Price · Currency is INR 98.10
-1.90 (-1.90%)
At close: Jun 17, 2026
Raghuvir Synthetics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,552 | 3,326 | 2,407 | 934.72 | 2,155 | |
Revenue Growth (YoY) | -23.27% | 38.15% | 157.55% | -56.62% | 23.70% |
Cost of Revenue | 2,071 | 2,604 | 1,744 | 748.37 | 1,783 |
Gross Profit | 480.8 | 722.1 | 663.64 | 186.35 | 371.71 |
Selling, General & Admin | 40.89 | 528.24 | 499.29 | 215.02 | 281.84 |
Other Operating Expenses | 345.46 | 5.83 | 3.89 | -8.7 | -0.2 |
Operating Expenses | 468.07 | 621.28 | 579.44 | 272.83 | 330.64 |
Operating Income | 12.73 | 100.82 | 84.2 | -86.48 | 41.07 |
Interest Expense | -24.64 | -30.34 | -36.57 | -29.12 | -6.61 |
Interest & Investment Income | - | 13.92 | 1.83 | 0.5 | 0.99 |
Currency Exchange Gain (Loss) | - | 0.05 | 5.19 | 0.26 | 3.54 |
Other Non Operating Income (Expenses) | - | 1.46 | 1.09 | 1.1 | -0.43 |
EBT Excluding Unusual Items | -11.91 | 85.91 | 55.73 | -113.74 | 38.57 |
Gain (Loss) on Sale of Investments | - | 1.27 | 0.92 | 0.31 | - |
Gain (Loss) on Sale of Assets | - | 0 | -5.32 | 0.36 | 2.56 |
Pretax Income | -11.91 | 87.19 | 51.33 | -113.06 | 41.13 |
Income Tax Expense | 0.91 | -2.71 | 4.79 | -14.74 | 7.09 |
Earnings From Continuing Operations | -12.82 | 89.9 | 46.53 | -98.32 | 34.04 |
Minority Interest in Earnings | 0.07 | 0.35 | 0.44 | 0.07 | 0.03 |
Net Income | -12.75 | 90.25 | 46.97 | -98.25 | 34.07 |
Net Income to Common | -12.75 | 90.25 | 46.97 | -98.25 | 34.07 |
Net Income Growth | - | 92.14% | - | - | -42.20% |
Shares Outstanding (Basic) | 39 | 39 | 39 | 39 | 39 |
Shares Outstanding (Diluted) | 39 | 39 | 39 | 39 | 39 |
Shares Change (YoY) | -0.26% | - | - | - | - |
EPS (Basic) | -0.33 | 2.33 | 1.21 | -2.54 | 0.88 |
EPS (Diluted) | -0.33 | 2.33 | 1.21 | -2.54 | 0.88 |
EPS Growth | - | 92.14% | - | - | -42.20% |
Free Cash Flow | -467.82 | 100.88 | 50.82 | -153.29 | 4.75 |
Free Cash Flow Per Share | -12.11 | 2.60 | 1.31 | -3.96 | 0.12 |
Gross Margin | 18.84% | 21.71% | 27.57% | 19.94% | 17.25% |
Operating Margin | 0.50% | 3.03% | 3.50% | -9.25% | 1.91% |
Profit Margin | -0.50% | 2.71% | 1.95% | -10.51% | 1.58% |
Free Cash Flow Margin | -18.33% | 3.03% | 2.11% | -16.40% | 0.22% |
EBITDA | 94.44 | 185.82 | 158.16 | -22.39 | 88.89 |
EBITDA Margin | 3.70% | 5.59% | 6.57% | -2.40% | 4.13% |
D&A For EBITDA | 81.72 | 85 | 73.96 | 64.1 | 47.82 |
EBIT | 12.73 | 100.82 | 84.2 | -86.48 | 41.07 |
EBIT Margin | 0.50% | 3.03% | 3.50% | -9.25% | 1.91% |
Effective Tax Rate | - | - | 9.34% | - | 17.24% |
Revenue as Reported | 2,567 | 3,367 | 2,443 | 960.23 | 2,186 |